Cargando…
Salivary gland ultrasound abnormalities in primary Sjögren’s syndrome: consensual US-SG core items definition and reliability
OBJECTIVES: Ultrasonography (US) is sensitive for detecting echostructural abnormalities of the major salivary glands (SGs) in primary Sjögren’s syndrome (pSS). Our objectives were to define selected US-SG echostructural abnormalities in pSS, set up a preliminary atlas of these definitions and evalu...
Autores principales: | Jousse-Joulin, Sandrine, Nowak, Emmanuel, Cornec, Divi, Brown, Jackie, Carr, Andrew, Carotti, Marina, Fisher, Benjamin, Fradin, Joel, Hocevar, Alojzija, Jonsson, Malin V, Luciano, Nicoletta, Milic, Vera, Rout, John, Theander, Elke, Stel, Aaltje, Bootsma, Hendrika, Vissink, Arjan, Baldini, Chiara, Baer, Alan, Ng, Wan Fai, Bowman, Simon, Alavi, Zarrin, Saraux, Alain, Devauchelle-Pensec, Valérie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575597/ https://www.ncbi.nlm.nih.gov/pubmed/28879042 http://dx.doi.org/10.1136/rmdopen-2016-000364 |
Ejemplares similares
-
Development and preliminary validation of the Sjögren’s Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren’s syndrome
por: Seror, Raphaele, et al.
Publicado: (2022) -
Incorporation of Salivary Gland Ultrasonography Into the American College of Rheumatology/European League Against Rheumatism Criteria for Primary Sjögren's Syndrome
por: van Nimwegen, Jolien F., et al.
Publicado: (2020) -
Normal salivary gland ultrasonography could rule out the diagnosis of Sjögren’s syndrome in anti-SSA-negative patients with sicca syndrome
por: Al Tabaa, Omar, et al.
Publicado: (2021) -
Hospitalisation rates among patients with primary Sjögren’s syndrome: a population-based study, 1995–2016
por: Maciel, Gabriel, et al.
Publicado: (2018) -
Efficacy and safety of abatacept in active primary Sjögren’s syndrome: results of a phase III, randomised, placebo-controlled trial
por: Baer, Alan N, et al.
Publicado: (2021)